-
1.发明申请公开(公告)号：US20090196935A1
公开(公告)日：2009-08-06
申请号：US12364241
申请日：2009-02-02
IPC分类号： A61K9/14 , A61K31/519 , A61P25/00
CPC分类号： A61K9/5073 , A61K9/5078 , A61K31/519 , A61K31/616 , A61K2300/00
摘要： The present invention is directed to pharmaceutical capsules comprising extended release formulations of dipyridamole, processes for preparing such dipyridamole extended release formulations and their use in the treatment of stroke.
摘要翻译： 本发明涉及包含双嘧达莫的延长释放制剂的药物胶囊，制备这种双嘧达莫延长释放制剂的方法及其在治疗中风中的应用。
-
公开(公告)号：US20110287096A1
公开(公告)日：2011-11-24
申请号：US13110591
申请日：2011-05-18
CPC分类号： A61K9/0065 , A61K9/0007 , A61K9/2081 , A61K9/5084 , A61K31/425 , A61K31/506 , A61K2300/00
摘要： Oral dosage forms for basic amine drugs, the dosage forms having a gastro-retentive component and a non gastro-retentive component. These dosage forms are capable of providing both IR and SR release rates for these drugs. In addition, they provide for release of the drug in the stomach and/or intestine of a mammal to which such dosage forms are administered. Such dosage forms include tablets and capsules. Such dosage forms provide improved bioavailability of otherwise poorly bioavailable basic amine drugs.
摘要翻译： 用于碱性胺药物的口服剂型，所述剂型具有胃保持成分和非保留性成分。 这些剂型能够提供这些药物的IR和SR释放速率。 此外，它们提供了在施用这种剂型的哺乳动物的胃和/或肠中释放药物。 这样的剂型包括片剂和胶囊剂。 这样的剂型提供了其他生物可利用的碱性胺药物的改善的生物利用度。
-
3.发明授权Non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising clozapine and methods of making and using the same 有权不含泡腾，口服崩解的包含氯氮平的固体药物剂型及其制备和使用方法公开(公告)号：US07811604B1
公开(公告)日：2010-10-12
申请号：US11598833
申请日：2006-11-14
申请人： Salah U. Ahmed , Lianli Li , Tahseen A. Chowdhury
发明人： Salah U. Ahmed , Lianli Li , Tahseen A. Chowdhury
CPC分类号： A61K9/2054 , A61K9/0056 , A61K9/2018 , A61K9/2027 , A61K31/5513
摘要： The present invention is directed to non-effervescent, orally disintegrating dosage forms comprising free base clozapine that are substantially free of acids, water-soluble polymers, taste-masking polymers, and coatings, and methods of making and using the same.
摘要翻译： 本发明涉及非泡腾口腔崩解剂型，其包含基本上不含酸的游离碱氯氮平，水溶性聚合物，掩味聚合物和涂层，以及制备和使用它们的方法。
-
4.发明授权Methods for treating vasomotor symptoms in castrated prostatic cancer patients with low dose cyproterone acetate 失效用低剂量醋酸环丙孕酮治疗阉割前列腺癌患者血管舒缩症状的方法公开(公告)号：US08288342B2
公开(公告)日：2012-10-16
申请号：US12577600
申请日：2009-10-12
IPC分类号： A61P5/26
摘要： The present invention is directed to methods of treating vasomotor symptoms in castrated prostatic cancer patients in need of treatment, comprising administering about 15 mg or less of cyproterone acetate per day to the patients. The present invention is further directed to dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate and a package comprising a plurality of dosage forms comprising about 1 mg to about 15 mg of cyproterone acetate.
摘要翻译： 本发明涉及在需要治疗的去势前列腺癌患者中治疗血管舒缩症状的方法，包括每天向患者施用约15mg或更少的醋酸环丙孕酮。 本发明还涉及包含约1mg至约15mg的醋酸环丙孕酮和包含多个剂型的包含约1mg至约15mg的醋酸环丙孕酮的剂型的剂型。
-
5.发明授权Orally disintegrating solid dosage forms comprising progestin and methods of making and using thereof 失效口服崩解包含孕激素的固体剂型及其制备和使用方法公开(公告)号：US08226980B2
公开(公告)日：2012-07-24
申请号：US12958975
申请日：2010-12-02
IPC分类号： A61K9/20
CPC分类号： A61K31/56 , A61K9/0056 , A61K9/2018 , A61K9/2054
摘要： The present invention is directed to non-effervescent, orally disintegrating solid pharmaceutical dosage forms comprising progestin and methods of making and using the dosage forms to treat conditions in females in need thereof.
摘要翻译： 本发明涉及包含孕激素的非泡腾口腔崩解固体药物剂型，以及制备和使用该剂型以治疗有需要的女性中的病症的方法。
-
6.发明授权公开(公告)号：US08217024B2
公开(公告)日：2012-07-10
申请号：US11645807
申请日：2006-12-27
IPC分类号： A61K31/56
CPC分类号： A61K9/0034 , A61K9/006 , A61K9/06 , A61K31/56 , A61K31/58 , A61K47/10 , A61K47/14 , A61K47/32 , A61K47/38 , A61K47/44
摘要： The present invention is directed to monophasic pharmaceutical compositions comprising a conjugated estrogen and a hydrophilic or lipophilic excipient. The present invention is also directed to kits and applicators comprising the pharmaceutical compositions. The invention is also directed to methods for treating menopausal conditions in a female comprising administration of the pharmaceutical compositions.
-
公开(公告)号：US07390503B1
公开(公告)日：2008-06-24
申请号：US10923021
申请日：2004-08-23
CPC分类号： A61K9/0056 , A61K9/2018 , A61K9/2027 , A61K9/2054
摘要： An ondansetron solid orally disintegrating dosage form for oral administration having at least one first water-dispersible component or water-insoluble cellulose derivative, a component having a —CHOH functional group, a disintegrating agent and at least one lubricant is provided. The dosage form can comprise ondansetron, a hydrophilic polymer such as microcrystalline cellulose, a component having a —CHOH functional group such as mannitol or xylitol and a disintegrating agent such as crospovidone. The lubricant may be a mixture of magnesium stearate, sodium stearyl fumarate and colloidal silicon dioxide. The present invention provides a non-effervescent tablet comprising the ondansetron dosage form. Another aspect of the invention is the treatment of emesis such as nausea and vomiting caused by cancer chemotherapy and radiation by the administration of the ondansetron formulation of the present composition. Finally, a process of forming an ondansetron disintegrating tablet using the ondansetron dosage form is disclosed.
摘要翻译： 提供了具有至少一种第一水分散性成分或水不溶性纤维素衍生物，具有-CHOH官能团的成分，崩解剂和至少一种润滑剂的口服的昂丹司琼固体口腔崩解剂型。 剂型可以包含昂丹司琼，亲水性聚合物如微晶纤维素，具有-CHOH官能团的组分如甘露醇或木糖醇和崩解剂如交聚维酮。 润滑剂可以是硬脂酸镁，硬脂酰富马酸钠和胶体二氧化硅的混合物。 本发明提供了包含昂丹司琼剂型的非泡腾片剂。 本发明的另一方面是通过施用本发明组合物的昂丹司琼制剂来治疗呕吐，例如由癌症化疗和放射引起的恶心和呕吐。 最后，公开了使用昂丹司琼剂型形成昂丹司琼崩解片的方法。
-
8.发明授权Monolithic intravaginal rings comprising progesterone and methods of making and uses thereof 有权包含孕酮的单体阴道内环及其制备方法和用途公开(公告)号：US08580293B2
公开(公告)日：2013-11-12
申请号：US12364990
申请日：2009-02-03
CPC分类号： A61K31/57 , A61F6/08 , A61K9/0036 , A61K47/34 , A61K47/44 , B29C45/0001 , B29C45/7207 , B29K2083/00 , B29K2105/0035 , B29L2031/753
摘要： The present invention relates to monolithic intravaginal rings comprising progesterone, methods of making, and uses thereof. The intravaginal rings comprise progesterone, a polysiloxane elastomer, and a pharmaceutically acceptable hydrocarbon or glycerol esters of a fatty acid.
摘要翻译： 本发明涉及包含孕酮的整体式阴道环，其制备方法和用途。 阴道内环包含孕酮，聚硅氧烷弹性体和药学上可接受的脂肪酸的烃或甘油酯。
-
9.发明授权Flexible, compressed intravaginal rings, methods of making and using the same, and apparatus for making the same 有权柔性，压缩的阴道内环，制造和使用它们的方法及其制造方法公开(公告)号：US08323679B2
公开(公告)日：2012-12-04
申请号：US12984729
申请日：2011-01-05
申请人： Salah U. Ahmed , Tahseen A. Chowdhury , Yi Luo
发明人： Salah U. Ahmed , Tahseen A. Chowdhury , Yi Luo
CPC分类号： A61K9/0036 , A61K31/00 , A61K31/20 , A61K38/00
摘要： The present invention is directed to flexible, compressed intravaginal rings comprising a substantially homogeneous compressed mixture comprising a polymethacrylate, a plasticizer, and an active agent, and methods of making and using the same, and apparatus for making the same.
摘要翻译： 本发明涉及柔性压缩阴道内环，其包含基本均匀的压缩混合物，其包含聚甲基丙烯酸酯，增塑剂和活性剂，以及制备和使用它们的方法及其制备方法。
-
10.发明授权Conjugated estrogen compositions, applicators, kits, and methods of making and use thereof 有权共轭雌激素组合物，施用器，试剂盒及其制备和使用方法公开(公告)号：US08247393B2
公开(公告)日：2012-08-21
申请号：US11889976
申请日：2007-08-17
IPC分类号： A61K31/56
CPC分类号： A61K9/0034 , A61K9/006 , A61K9/06 , A61K31/56 , A61K31/58 , A61K47/10 , A61K47/14 , A61K47/32 , A61K47/38 , A61K47/44
摘要： The present invention is directed to monophasic pharmaceutical compositions comprising a conjugated estrogen and a hydrophilic or lipophilic excipient. The present invention is also directed to kits and applicators comprising the pharmaceutical compositions. The invention is also directed to methods for treating menopausal conditions in a female comprising administration of the pharmaceutical compositions.
摘要翻译： 本发明涉及包含共轭雌激素和亲水或亲脂性赋形剂的单相药物组合物。 本发明还涉及包含药物组合物的试剂盒和施用器。 本发明还涉及用于治疗女性的更年期病症的方法，其包括给予药物组合物。
-
-
-
-
-
-
-
-
-
搜索结果
18 条记录 (耗时 0.034 秒)
